Designing anti-inflammatory probiotics to treat chronic lung inflammation. Ghent University
While inflammation is key to our body’s defence against pathogens, an uncontrolled pro-inflammatory reaction can lead to tissue deterioration and ultimately death. Chronic lung inflammation is the main driver of pathogenesis in patients with chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF). In COPD patients, chronic lung inflammation is mainly triggered by cigarette smoke exposure, while in CF patients this is due to ...